HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


INCY: Incyte Genomics Inc - Detailed Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage
INCYTE GENOMICS INC (NASD)
INCY 7.55 -0.17 (-2.20%) Vol.  2,523,198 16:00 ET
Last 7.55 Bid / Size 6.87x0
Net  -0.17 Ask / Size 8.24x0
% Change  -2.20 52 Wk High 8.32
High 7.80 52 Wk Low 1.96
Low 7.41 Volume 2,523,198
 
Insider Ownership 24.4% S&P 500 Member NO
Institutional Ownership 71.48% Beta 2.37
P/E (TTM) PEG Ratio
PE (forward) Price / Sales 262.04
 
Dividend N/A
Dividend Yield 0
Last Dividend Date N/A
5 Year Avg. Yield 0
Dividend Payout Ratio
 
Shares Outstanding N/A
Market Capitalization 894,977,000
Last Split Date 09/01/2000
Split Factor 2
Short Interest Ratio 3.03
 
% Change
4 Weeks 27.32
12 Weeks 17.6
52 Weeks 203.21
 
% Change Relative to S&P 500
4 Weeks 27.5
12 Weeks 11.09
52 Weeks 109.05

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research